Keyphrases
Indonesia
100%
Jakarta
37%
Indonesian
36%
COVID-19
30%
Type 2 Diabetes Mellitus (T2DM)
28%
Risk Factors
25%
Asia
20%
Pada
20%
Meta-analysis
14%
Liver Cirrhosis
13%
Confidence Interval
12%
Helicobacter Pylori (H. pylori)
12%
Helicobacter Pylori Infection
12%
Type 1 Diabetes Mellitus (T1DM)
11%
Antiretroviral Therapy
11%
Type 2 Diabetic Patients
11%
HIV Patients
11%
AIDS/HIV
11%
Hepatocellular Carcinoma
10%
Asia-Pacific
10%
Obesity
10%
Gastroesophageal Reflux Disease
10%
Inflammatory Bowel Disease
9%
Hypertension
9%
Systematic Meta-analysis
9%
COVID-19 Pandemic
9%
Quality of Life
9%
Body Mass Index
9%
Retrospective Cohort Study
8%
Non-alcoholic Fatty Liver Disease (NAFLD)
8%
Nutritional Status
8%
Diabetes
8%
High Risk
8%
Colorectal Cancer
8%
General Hospital
7%
Acute Coronary Syndrome
7%
Randomized Controlled Trial
7%
Endoscopy
7%
Elderly Patients
7%
Type 2 Diabetes Mellitus Patients
7%
Referral Hospital
7%
Tuberculosis
7%
Multivariate Analysis
7%
Asia-Pacific Region
7%
Insulin Resistance
7%
Dyspepsia
7%
Odds Ratio
6%
Cancer Patients
6%
COVID-19 Patients
6%
Hepatitis C Virus
6%
Liver
6%
Rheumatoid Arthritis
6%
Comorbidity
5%
Hepatitis C
5%
Autoimmune Disease
5%
Interleukin-6
5%
Prospective Cohort Study
5%
South-East Asia
5%
Diabetic Foot Ulcer
5%
Inflammation
5%
People Living with HIV (PLHIV)
5%
Chemotherapy
5%
Fasting Plasma Glucose
5%
Cirrhosis
5%
Hemoglobin A1c (HbA1c)
5%
Clinical Outcomes
5%
Endoscopic Retrograde Cholangiopancreatography
5%
Cardiovascular Disease
5%
Rheumatoid Arthritis Patients
5%
Hospitalization
5%
Proton Pump Inhibitors
5%
Bleeding
5%
Etiology
5%
Chronic Kidney Disease
5%
Sepsis
5%
Clinical Manifestations
5%
Consensus Recommendations
5%
Tumor Necrosis Factor-α
5%
Malignancy
5%
Medical Records
5%
Medicine and Dentistry
COVID-19
38%
Disease
29%
Human Immunodeficiency Virus
26%
Prevalence
24%
Maturity Onset Diabetes of the Young
23%
Infection
22%
Diagnosis
21%
Symptom
19%
Cross Sectional Study
17%
Diabetes
15%
Liver Cirrhosis
15%
Diabetes Mellitus
14%
Malignant Neoplasm
13%
Quality of Life
11%
Meta-Analysis
10%
Hepatocellular Carcinoma
10%
Patient Referral
10%
Gastroesophageal Reflux
10%
Systematic Review
10%
Body Mass Index
10%
Inflammatory Bowel Disease
9%
Dyspepsia
8%
Helicobacter Infection
8%
Antiretroviral Therapy
8%
Bleeding
8%
Cancer
8%
Endoscopy
8%
Colorectal Cancer
8%
Endoscopic Ultrasound
7%
Nonalcoholic Fatty Liver
7%
Neoplasm
7%
Elderly Patient
7%
Retrospective Cohort Study
7%
Health Care Cost
7%
Randomized Controlled Trial
7%
Helicobacter Pylori
6%
Chronic Kidney Disease
6%
Cardiovascular Disease
6%
Geriatrics
6%
Cohort Analysis
6%
Hemodialysis
6%
Portal Hypertension
6%
Colonoscopy
6%
Cohort Effect
6%
Midazolam
6%
Endoscopic Retrograde Cholangiopancreatography
5%
Sepsis
5%
Pylorus
5%
Placebo
5%
Nutritional Status
5%
Odds Ratio
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Biopsy
5%
Mortality Rate
5%
Cardiovascular System
5%
Fibrosis
5%
Biological Marker
5%
Multivariate Analysis
5%
Drug Therapy
5%
Acute Coronary Syndrome
5%
Hepatitis C
5%
Blood Glucose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
37%
Infection
30%
Prevalence
30%
Non Insulin Dependent Diabetes Mellitus
26%
HIV
23%
Cross-Sectional Study
18%
Diabetes Mellitus
15%
Symptom
14%
Malignant Neoplasm
13%
Cohort Study
12%
Coronavirinae
12%
Liver Cirrhosis
10%
Liver Cell Carcinoma
9%
Colorectal Cancer
9%
Inflammation
9%
Vaccination Policy
9%
Chemotherapy
8%
Helicobacter Pylori
8%
Hemodialysis
8%
Randomized Controlled Trial
8%
Helicobacter Infection
8%
Placebo
7%
Cardiovascular Disease
7%
Adverse Event
7%
Nonalcoholic Fatty Liver
6%
Acute Coronary Syndrome
6%
Hepatitis C
6%
Antibiotics
6%
Vitamin D
6%
Dyspepsia
6%
Neoplasm
6%
Comorbidity
6%
Chronic Kidney Failure
6%
Gastroesophageal Reflux
6%
Hepatitis B Virus
6%
Rheumatoid Arthritis
6%
Mortality Rate
5%
Autoimmune Disease
5%
Systemic Lupus Erythematosus
5%
Frailty
5%
Tumor Necrosis Factor
5%
Midazolam
5%
SARS Coronavirus
5%
Hepatitis C Virus
5%
Insulin Resistance
5%
Biological Marker
5%
Cytokine
5%
Atherosclerosis
5%
Hepatitis B
5%